---
$id: https://graph.org.ai/products/commodity/51201803
$type: Product
source: UNSPSC
code: "51201803"
title: "Pegfilgrastim"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pegfilgrastim

**UNSPSC Code**: 51201803
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic colony stimulating factor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3A58010674. European Medicines Agency schedules Pegfilgrastim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16451MIG. Pegfilgrastim generally arises in the molecular formula C3H8NO(C2H4O)N. The term PEGFILGRASTIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations schedule pegfilgrastim under HS 39072021 and SITC 57419. As of Q4 2014, PEGFILGRASTIM remains the US FDA Preferred Term for this commodity. Pegfilgrastim bears US NLM identifiers UMLS ID C1171279 and NCI Concept Code C1854. SMILES: NONE.

